Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.5K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.5K
Stem Cell Culture01:17

Stem Cell Culture

5.9K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.9K
Embryonic Stem Cells00:57

Embryonic Stem Cells

4.5K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.5K
Embryonic Stem Cells00:58

Embryonic Stem Cells

31.9K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
31.9K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

5.4K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer.

Cancer research·2013
Same author

Astragaloside II triggers T cell activation through regulation of CD45 protein tyrosine phosphatase activity.

Acta pharmacologica Sinica·2013
Same author

Digital design and individually fabricated titanium implants for the reconstruction of traumatic zygomatico-orbital defects.

The Journal of craniofacial surgery·2013
Same author

Screening for and surveillance of high-risk patients with HBV-related chronic liver disease: promoting the early detection of hepatocellular carcinoma in China.

Bioscience trends·2013
Same author

Synthesis and hepatitis C antiviral activity of 1-aminobenzyl-1H-indazole-3-carboxamide analogues.

ChemMedChem·2013
Same author

Thyroid function and morphology in overweight and obese children and adolescents in a Chinese population.

Journal of pediatric endocrinology & metabolism : JPEM·2013

Related Experiment Videos

Challenges and advances in stem cell therapy.

Wei Tang1,2

  • 1International Health Care Center, National Center for Global Health and Medicine.

Bioscience Trends
|September 19, 2019
PubMed
Summary
This summary is machine-generated.

Stem cell therapy holds promise for treating diseases like heart disease and diabetes. Cell sheet and secretome therapies address challenges like tumorigenicity and scalability, paving the way for future medical breakthroughs.

Keywords:
Stem cellcell sheetregenerative medicinesecretometissue engineering

Related Experiment Videos

Area of Science:

  • Regenerative Medicine
  • Cell Biology
  • Biotechnology

Background:

  • Stem cells offer potential therapeutic applications for diverse diseases including cardiovascular, metabolic, and neurological disorders.
  • Significant hurdles impede clinical translation, including the tumorigenic potential of undifferentiated human induced pluripotent stem cells (hiPSC), limitations in large-scale cell culture, and logistical challenges of cell administration.

Discussion:

  • Cell sheet technology and secretome therapy are emerging strategies to overcome current limitations in stem cell therapy.
  • These innovative approaches aim to enhance safety, improve scalability, and simplify the delivery of stem cell-based treatments.

Key Insights:

  • Stem cells show promise for treating various diseases but face clinical translation challenges.
  • hiPSC tumorigenicity, culture scalability, and therapy inconvenience are key obstacles.
  • Cell sheet and secretome therapies offer potential solutions to these challenges.

Outlook:

  • Continued advancements in stem cell research and technology are expected to drive significant progress in regenerative medicine.
  • Stem cell therapy is poised to revolutionize medical treatment paradigms in the near future.
  • The integration of novel technologies will accelerate the transition of stem cell therapies from laboratory research to clinical practice.